SELLERS ROBERT W.A.
Known title: SVP, Corporate ControllerCIK: 0001600739
Associated companies
Transaction History
| EW | ▼ Sell | Tax Withholding | 229 | $20K | 5/11/2024 | View on chart |
| EW | ▲ Buy | Grant | 2,445 | $0 | 5/7/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 178 | $15K | 5/7/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 120 | $10K | 5/4/2024 | View on chart |
| EW | ▼ Sell | Tax Withholding | 106 | $9K | 5/3/2024 | View on chart |
| EW | ▲ Buy | Grant | 1,998 | $0 | 2/22/2024 | View on chart |
| EW | ▲ Buy | Option Exercise | 12,210 | $449K | 2/12/2024 | View on chart |
| EW | ▼ Sell | Open Market | 12,210 | $1.1M | 2/12/2024 | View on chart |
| EW | ▲ Buy | Grant | 1,800 | $0 | 5/11/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 161 | $14K | 5/8/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 134 | $12K | 5/7/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 116 | $10K | 5/4/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 103 | $9K | 5/3/2023 | View on chart |
| EW | ▲ Buy | Option Exercise | 12,270 | $432K | 4/28/2023 | View on chart |
| EW | ▼ Sell | Open Market | 12,270 | $1.1M | 4/28/2023 | View on chart |
| EW | ▼ Sell | Tax Withholding | 211 | $20K | 5/17/2022 | View on chart |
| EW | ▼ Sell | Tax Withholding | 155 | $16K | 5/8/2022 | View on chart |
| EW | ▼ Sell | Tax Withholding | 134 | $13K | 5/7/2022 | View on chart |
| EW | ▼ Sell | Tax Withholding | 116 | $12K | 5/4/2022 | View on chart |
| EW | ▲ Buy | Grant | 1,180 | $0 | 5/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
EW: FDA Flags High-Risk Device Recall After Patient Death
The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.
EW: FDA Flags High-Risk Device Recall After Patient Death. The U.S. Food and Drug Administration flagged a potentially high-risk issue with Edwards Lifesciences' SAPIEN M3 delivery system, specifically the Commander M system, after a patient death was reported. The company has instructed customers to remove four specific lots of the device from use. This regulatory action highlights a significant safety concern for the company's key product line, drawing close regulatory scrutiny.